Enrico Maria Pogliani
Overview
Explore the profile of Enrico Maria Pogliani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, et al.
J Clin Oncol
. 2016 Jul;
35(6):605-612.
PMID: 27400939
Purpose The initial results of the APL0406 trial showed that the combination of all- trans-retinoic acid (ATRA) and arsenic trioxide (ATO) is at least not inferior to standard ATRA and...
2.
Alberti P, Parma M, Pioltelli P, Pogliani E, Terruzzi E, Stasia A, et al.
J Peripher Nerv Syst
. 2016 Apr;
21(3):154-6.
PMID: 27117493
No abstract available.
3.
Carpenedo M, Cantoni S, Coccini V, Pogliani E, Cairoli R
Eur J Haematol
. 2016 Jan;
97(1):101-103.
PMID: 26718013
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts resulting from both immune-mediated platelet destruction and inappropriate bone marrow platelet production. Therefore, in patients with ITP failing...
4.
Aroldi A, Cecchetti C, Colombo A, Cattaneo L, Pioltelli P, Pogliani E, et al.
Eur J Haematol
. 2015 Jul;
96(6):593-601.
PMID: 26205460
Patients with essential thrombocythemia (ET) often suffer from neurological symptoms (NS) not ever resulting from previous thrombotic cerebral events (TCE). We reported NS occurred in 282 patients, in order to...
5.
LImperio V, Fabbrini P, Ferrario F, Pieruzzi F, Tosoni A, Brivio R, et al.
Kidney Int
. 2015 Jul;
88(1):200-2.
PMID: 26126102
No abstract available.
6.
Parma M, Vigano C, Fumagalli M, Colnaghi F, Colombo A, Mottadelli F, et al.
Mediterr J Hematol Infect Dis
. 2015 Jun;
7(1):e2015041.
PMID: 26075048
Background And Objectives: Acute lymphoblastic leukaemia (ALL) carrying t(9;22) or t(4;11) genetic abnormalities represents a very high risk subtype of disease (VHR-ALL). Hematopoietic stem cell transplantation (HSCT) remains the best...
7.
Carpenedo M, Cantoni S, Coccini V, Fedele M, Morra E, Pogliani E
Hematol Rep
. 2015 Apr;
7(1):5673.
PMID: 25852848
Thrombopoietin mimetics are new treatment options for patients with immune throm-bocytopenia (ITP). Because of their mechanism of action, long-term administration was envisioned in order to maintain effective thrombopoiesis. We report...
8.
Bassan R, Masciulli A, Intermesoli T, Audisio E, Rossi G, Pogliani E, et al.
Haematologica
. 2015 Mar;
100(6):786-93.
PMID: 25749825
Developing optimal radiation-free central nervous system prophylaxis is a desirable goal in acute lymphoblastic leukemia, to avoid the long-term toxicity associated with cranial irradiation. In a randomized, phase II trial...
9.
Fianchi L, Pagano L, Piciocchi A, Candoni A, Gaidano G, Breccia M, et al.
Am J Hematol
. 2015 Feb;
90(5):E80-5.
PMID: 25653205
Therapy-related myeloid neoplasms (t-MN) are a complication of cytotoxic treatment for primary tumors and autoimmune diseases. We report data on 277 t-MN patients, recruited between 1999 and 2013 by the...
10.
Piccin A, Steurer M, Mitterer M, Blochl E, Marcheselli L, Pusceddu I, et al.
Intern Emerg Med
. 2015 Jan;
10(4):451-60.
PMID: 25585678
Patients with essential thrombocythemia (ET) aged less than 60 years, who have not suffered a previous vascular event (low-risk patients), may develop thrombotic or hemorrhagic events. So far, it has...